Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The nominally significant correlations included positive associations between never or former smoking and use of multivitamins, vitamin D, magnesium, probiotics, calcium, and multiminerals; between age and calcium use; and between income and probiotic use.

Source: Correlates of supplement type. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Dietary supplements are commonly used for menopause symptoms amid concerns about hormone therapy: a cross-sectional study

Source: Article title.

This cross-sectional study assessed current dietary supplement use, including use specifically for menopause symptoms, and perceptions of menopausal hormone therapy (MHT) among symptomatic menopausal women aged 45 to 65 years.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Dietary supplements are commonly used for menopause symptoms amid concerns about hormone therapy: a cross-sectional study

Cross-sectional study · Frontiers in Global Women's Health · 2026

Original publication title

Dietary supplements are commonly used for menopause symptoms amid concerns about hormone therapy: a cross-sectional study

Susanne Mitschke

© 2026 Mitschke.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In this self-selected online sample, current dietary supplement use for any purpose was common, although fewer than half of supplement users reported using supplements to manage menopause symptoms. Concerns about MHT persisted despite high awareness. These estimates should not be generalized to the broader population of midlife women. Future studies using probability-based samples and validated symptom measures are needed to characterize menopause-targeted supplement use and to inform clinical strategies that support individualized menopause care.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Many women use dietary supplements to manage menopause symptoms, yet patterns of use, perceived effectiveness, and information sources remain incompletely described in contemporary literature. This cross-sectional study assessed current dietary supplement use, including use specifically for menopause symptoms, and perceptions of menopausal hormone therapy (MHT) among symptomatic menopausal women aged 45 to 65 years.

Source: Objective

Abstract: What methods does the paper describe?

An online questionnaire was administered to a self-selected sample of 226 perimenopausal or postmenopausal participants recruited through online health forums, social media, menopause support groups, and newsletters. Survey items captured sociodemographic characteristics, health, supplement use, perceived effectiveness, information sources, and MHT awareness and concerns. Associations were examined using cross-tabulations, chi-square and exact tests, Spearman correlations, and logistic regression.

Source: Methods

Abstract: Results

Current use of at least one dietary supplement, for any purpose, was reported by 138 participants (61.1%; 95% CI 54.6 to 67.2). Self-reported use of supplements specifically to manage menopause symptoms (menopause-targeted use) was reported by 65 participants (28.9%; 95% CI 23.4 to 35.1). Among supplement users, the most frequently reported products were multivitamins (55.8%), vitamin D (52.9%), magnesium (51.4%), and probiotics (41.3%). MHT awareness was high (n = 187, 82.7%) and increased with income. Concerns about breast cancer (47.8%), blood clotting (44.7%), stroke (40.7%), and heart disease (37.2%) as risks of MHT were frequently reported.

Healthcare providers and online sources were the leading sources of information, and social media influencers were rated least trustworthy. Former smokers (adjusted OR 2.98, 95% CI 1.21 to 7.34) and never smokers (adjusted OR 3.92, 95% CI 1.59 to 9.65) had higher odds of any supplement use than current smokers; this association was not observed for menopause-targeted use.

Source: Results

Abstract: Conclusion

In this self-selected online sample, current dietary supplement use for any purpose was common, although fewer than half of supplement users reported using supplements to manage menopause symptoms. Concerns about MHT persisted despite high awareness. These estimates should not be generalized to the broader population of midlife women. Future studies using probability-based samples and validated symptom measures are needed to characterize menopause-targeted supplement use and to inform clinical strategies that support individualized menopause care.

Source: Conclusion
Authors’ abstract

Objective

Many women use dietary supplements to manage menopause symptoms, yet patterns of use, perceived effectiveness, and information sources remain incompletely described in contemporary literature. This cross-sectional study assessed current dietary supplement use, including use specifically for menopause symptoms, and perceptions of menopausal hormone therapy (MHT) among symptomatic menopausal women aged 45 to 65 years.

Methods

An online questionnaire was administered to a self-selected sample of 226 perimenopausal or postmenopausal participants recruited through online health forums, social media, menopause support groups, and newsletters. Survey items captured sociodemographic characteristics, health, supplement use, perceived effectiveness, information sources, and MHT awareness and concerns. Associations were examined using cross-tabulations, chi-square and exact tests, Spearman correlations, and logistic regression.

Results

Current use of at least one dietary supplement, for any purpose, was reported by 138 participants (61.1%; 95% CI 54.6 to 67.2). Self-reported use of supplements specifically to manage menopause symptoms (menopause-targeted use) was reported by 65 participants (28.9%; 95% CI 23.4 to 35.1). Among supplement users, the most frequently reported products were multivitamins (55.8%), vitamin D (52.9%), magnesium (51.4%), and probiotics (41.3%). MHT awareness was high (n = 187, 82.7%) and increased with income. Concerns about breast cancer (47.8%), blood clotting (44.7%), stroke (40.7%), and heart disease (37.2%) as risks of MHT were frequently reported.

Healthcare providers and online sources were the leading sources of information, and social media influencers were rated least trustworthy. Former smokers (adjusted OR 2.98, 95% CI 1.21 to 7.34) and never smokers (adjusted OR 3.92, 95% CI 1.59 to 9.65) had higher odds of any supplement use than current smokers; this association was not observed for menopause-targeted use.

Conclusion

In this self-selected online sample, current dietary supplement use for any purpose was common, although fewer than half of supplement users reported using supplements to manage menopause symptoms. Concerns about MHT persisted despite high awareness. These estimates should not be generalized to the broader population of midlife women. Future studies using probability-based samples and validated symptom measures are needed to characterize menopause-targeted supplement use and to inform clinical strategies that support individualized menopause care.

Publication and source details

Original title: Dietary supplements are commonly used for menopause symptoms amid concerns about hormone therapy: a cross-sectional study

Susanne Mitschke

Frontiers in Global Women's Health · 2026

* Correspondence: Susanne Mitschke susanne.mitschke@alumni.harvard.edu© 2026 Mitschke.2026Mitschkehttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:27:45.119294+00:00

DOI: 10.3389/fgwh.2026.1924461 · PMC13714707